Landiolol is a beta-blocker medication used for the treatment of irregular heartbeats. Impurities in Landiolol may occur due to various factors such as the manufacturing process or storage conditions. These impurities, if present in high levels, can affect the quality and safety of the medication. Therefore, it is important to monitor and control the impurities in Landiolol to ensure its efficacy and safety for patients.
Toref has specialization in the synthesis / supply of pharmacopeia impurities, process impurities, isolation, and identification of unknown impurities of Landiolol to all pharmaceutical companies globally. All ready-to-ship Landiolol Impurities are tabulated below:
|Product Name||CAS No.||Molecular Formula||Molecular Weight||Purity|
|Landiolol Impurity 4||190601-22-0||C19H29N3O6||395.45||N/A|
|Landiolol Impurity 9||N/A||C24H28O7||428.48||96.03%|
|Landiolol Impurity 16||N/A||C22H35N308||469.24||92.76%|
|Landiolol Impurity 17||N/A||C18H24O6||336.38||99.12%|
|Landiolol Impurity 18||N/A||C18H24O6||336.38||96.68%|
Contact us now for an instant quote. We can provide you with research material for nearly every pharmaceutical impurity you want!